Thrivent Financial For Lutherans Medpace Holdings, Inc. Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 120,928 shares of MEDP stock, worth $39.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
120,928
Previous 14,430 738.03%
Holding current value
$39.6 Million
Previous $4.82 Million 734.05%
% of portfolio
0.08%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$308.93 - $363.58 $32.9 Million - $38.7 Million
106,498 Added 738.03%
120,928 $40.2 Million
Q3 2024

Nov 07, 2024
BUY
$320.58 - $457.29 $1.76 Million - $2.51 Million
5,484 Added 61.3%
14,430 $4.82 Million
Q2 2024

Aug 13, 2024
BUY
$372.0 - $424.34 $1.02 Million - $1.16 Million
2,741 Added 44.17%
8,946 $3.69 Million
Q1 2024

May 14, 2024
BUY
$284.87 - $413.31 $5,412 - $7,852
19 Added 0.31%
6,205 $2.51 Million
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $2,275 - $3,126
-10 Reduced 0.16%
6,186 $1.9 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $7.73 Million - $9.31 Million
-33,040 Reduced 84.21%
6,196 $1.5 Million
Q2 2023

Aug 14, 2023
SELL
$187.26 - $240.17 $4.95 Million - $6.35 Million
-26,424 Reduced 40.24%
39,236 $9.42 Million
Q1 2023

May 17, 2023
SELL
$174.31 - $239.52 $53 Million - $72.9 Million
-304,279 Reduced 82.25%
65,660 $12.3 Million
Q4 2022

Feb 08, 2023
BUY
$153.06 - $226.57 $33.5 Million - $49.5 Million
218,554 Added 144.37%
369,939 $78.6 Million
Q3 2022

Nov 14, 2022
BUY
$145.13 - $182.49 $20.9 Million - $26.3 Million
144,323 Added 2043.66%
151,385 $23.8 Million
Q2 2022

Aug 16, 2022
SELL
$130.2 - $168.03 $58,720 - $75,781
-451 Reduced 6.0%
7,062 $1.06 Million
Q1 2022

May 13, 2022
SELL
$138.87 - $214.31 $9,443 - $14,573
-68 Reduced 0.9%
7,513 $1.23 Million
Q4 2021

Feb 16, 2022
BUY
$182.74 - $227.9 $16,629 - $20,738
91 Added 1.21%
7,581 $1.65 Million
Q3 2021

Nov 15, 2021
BUY
$170.18 - $198.21 $23,314 - $27,154
137 Added 1.86%
7,490 $1.42 Million
Q2 2021

Aug 19, 2021
BUY
$158.62 - $194.3 $6,027 - $7,383
38 Added 0.52%
7,353 $1.3 Million
Q1 2021

May 17, 2021
BUY
$132.02 - $168.26 $13,730 - $17,499
104 Added 1.44%
7,315 $1.2 Million
Q4 2020

Feb 16, 2021
SELL
$109.38 - $149.19 $14,438 - $19,693
-132 Reduced 1.8%
7,211 $1 Million
Q3 2020

Nov 10, 2020
SELL
$92.95 - $130.61 $1.41 Million - $1.98 Million
-15,160 Reduced 67.37%
7,343 $821,000
Q2 2020

Aug 12, 2020
SELL
$68.08 - $95.68 $30,363 - $42,673
-446 Reduced 1.94%
22,503 $2.09 Million
Q1 2020

May 15, 2020
BUY
$61.71 - $101.95 $70,657 - $116,732
1,145 Added 5.25%
22,949 $1.68 Million
Q4 2019

Feb 13, 2020
BUY
$70.08 - $84.64 $17,379 - $20,990
248 Added 1.15%
21,804 $1.83 Million
Q3 2019

Nov 14, 2019
BUY
$62.38 - $85.89 $69,678 - $95,939
1,117 Added 5.47%
21,556 $1.81 Million
Q2 2019

Aug 13, 2019
BUY
$53.64 - $65.42 $30,628 - $37,354
571 Added 2.87%
20,439 $1.34 Million
Q1 2019

May 14, 2019
BUY
$49.38 - $70.58 $71,946 - $102,835
1,457 Added 7.91%
19,868 $1.17 Million
Q4 2018

Feb 15, 2019
SELL
$46.97 - $63.98 $2.21 Million - $3.01 Million
-47,012 Reduced 71.86%
18,411 $974,000
Q3 2018

Nov 15, 2018
BUY
$43.25 - $63.74 $1.51 Million - $2.23 Million
34,997 Added 115.02%
65,423 $3.92 Million
Q2 2018

Aug 14, 2018
SELL
$34.03 - $45.46 $838,397 - $1.12 Million
-24,637 Reduced 44.74%
30,426 $1.31 Million
Q1 2018

May 08, 2018
SELL
$32.03 - $39.05 $241,794 - $294,788
-7,549 Reduced 12.06%
55,063 $1.92 Million
Q4 2017

Feb 14, 2018
BUY
$32.46 - $38.31 $2.03 Million - $2.4 Million
62,612
62,612 $2.27 Million

Others Institutions Holding MEDP

# of Institutions
625
Shares Held
25.7M
Call Options Held
74.3K
Put Options Held
79.1K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email